These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21778948)

  • 1. Notch1 identified as a prognostic factor for glioma patients.
    Engh JA
    Neurosurgery; 2011 Jun; 68(6):N22-3. PubMed ID: 21778948
    [No Abstract]   [Full Text] [Related]  

  • 2. Notch1 is an independent prognostic factor for patients with glioma.
    Li J; Cui Y; Gao G; Zhao Z; Zhang H; Wang X
    J Surg Oncol; 2011 Jun; 103(8):813-7. PubMed ID: 21241024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 expression is upregulated in glioma and is associated with tumor progression.
    Jiang L; Wu J; Chen Q; Hu X; Li W; Hu G
    J Clin Neurosci; 2011 Mar; 18(3):387-90. PubMed ID: 21251836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients].
    Sun ZF; Wang L; Gu F; Fu L; Li WL; Ma YJ
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):26-30. PubMed ID: 22490851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of PCDH9 predicts prognosis for patients with glioma.
    Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z
    J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global histone modification patterns as prognostic markers to classify glioma patients.
    Liu BL; Cheng JX; Zhang X; Wang R; Zhang W; Lin H; Xiao X; Cai S; Chen XY; Cheng H
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2888-96. PubMed ID: 20978174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain tumor stem cells.
    Sulman E; Aldape K; Colman H
    Curr Probl Cancer; 2008; 32(3):124-42. PubMed ID: 18501775
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic and predictive markers in glioma and other neuroepithelial tumors.
    Rivera AL; Pelloski CE; Sulman E; Aldape K
    Curr Probl Cancer; 2008; 32(3):97-123. PubMed ID: 18501774
    [No Abstract]   [Full Text] [Related]  

  • 9. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients.
    Field M; Alvarez A; Bushnev S; Sugaya K
    Clin Neurosurg; 2010; 57():151-9. PubMed ID: 21280509
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker.
    Laggner U; Pipp I; Budka H; Hainfellner JA; Preusser M
    Histopathology; 2007 Jun; 50(7):949-52. PubMed ID: 17543088
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic role of Ki-67 in childhood low-grade glioma.
    Maurizi P; Ruggiero A; Attinà G; Cefalo MG; Arlotta A; Riccardi R
    Pediatr Med Chir; 2008; 30(2):73-8. PubMed ID: 18581959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution of immunoregulatory carbohydrate lectin receptors on glioma cell membranes and autologus peripheral mononuclears in neuro-oncological patients depending upon the degree of brain tumor anaplasia].
    Gnedkova IA; Licianyi' NI; Romodanov SA; Glavatskii' AI; Brodskaia IA; Shmeleva AA; Gerasenko KM; Khmel'nitskii' GV
    Biull Eksp Biol Med; 1996 Oct; 122(10):441-5. PubMed ID: 9081446
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers and cancer stem cells in primary brain tumors. Foreword.
    Bogler O; Sawaya R
    Curr Probl Cancer; 2008; 32(3):95-6. PubMed ID: 18501773
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.
    Zhao Y; Xue Y; Liu Y; Fu W; Jiang N; An P; Wang P; Yang Z; Wang Y
    Br J Neurosurg; 2005 Aug; 19(4):322-6. PubMed ID: 16455538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of Aurora-B in human glioma tissue and its significance].
    Sun LB; Fu SL; Luo YN; Chen H; Li WC; Ge PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):47-9. PubMed ID: 19218110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
    Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and cytogenetic factors of prognosis in glial tumors of the brain].
    Dreval' ON; Belokhvostov AS; Feniksov VM
    Zh Vopr Neirokhir Im N N Burdenko; 2009; (4):7-12; discussion 12-3. PubMed ID: 20143607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of diagnostic neuronal markers and outcome in glioblastoma.
    Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.